Why the study?
Does platelet function testing to guide antiplatelet therapy improve outcomes in patients with acute coronary syndrome or those undergoing percutaneous coronary intervention?
Population
Patients with acute coronary syndrome and patients undergoing percutaneous coronary intervention
Design
Review
Authors
Loading...
Does not support routine use; leaves open individualized therapy in high-risk PCI pending prospective trials.
Does platelet function testing to guide antiplatelet therapy improve outcomes in patients with acute coronary syndrome or those undergoing percutaneous coronary intervention?
While routine platelet function testing remains uncertain, it may be useful to individualize antiplatelet therapy in high-risk patients undergoing percutaneous coronary intervention.
Rakesh K Sharma (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: